Heme Oxygenase-1 in Bone Remodeling: Molecular Mechanisms and Therapeutic Implications
Biomolecules · 2026
DOI: 10.3390/biom16091224 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Thanawat Pattananandecha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: Heme Oxygenase-1, Bone Remodeling. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chiang Mai University.
Abstract (Originalsprache)
Bone remodeling is a dynamic and tightly regulated process that maintains skeletal homeostasis through a balance between bone formation by osteoblasts and bone resorption by osteoclasts. Disruption of this balance contributes to the development of bone-related disorders, particularly osteopenia, osteoporosis and osteogenesis imperfecta, which weaken, deform, or cause fractures. Increasing evidence indicates that oxidative stress and chronic inflammation impair osteoblast functions while promoting osteoclast differentiation and activity. Heme oxygenase-1 (HO-1) is a stress-inducible enzyme with cytoprotective, antioxidant, and anti-inflammatory properties. Besides its primary role in cellular defense against oxidative stress and inflammatory damage, HO-1 has been shown to be involved in both osteoblast differentiation and osteoclastogenesis. Through its interaction with key regulatory systems, including the receptor activator of nuclear factor κB (RANK)–receptor activator of nuclear factor κB ligand (RANKL)–osteoprotegerin axis and redox-sensitive signaling pathways, HO-1 contributes to maintenance of optimal bone remodeling. The enzyme also plays a role in modulating metabolic processes in the bone. This review highlights the role of HO-1 in bone formation, bone resorption, and related pathophysiologic conditions. Furthermore, the therapeutic potential of HO-1 as a target for bone disorders is discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.
- Research Center for Innovation in Analytical Science and Technology for Biodiversity-Based Economic and Society (I-ANALY-S-T_B.BES-CMU), Chiang Mai University, Chiang Mai 50200, Thailand.
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
- College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
ORCID-Profile: Thanawat Pattananandecha, Sutasinee Apichai, Chalermpong Saenjum
Förderung
- Chiang Mai University
Zitieren
APA
Pattananandecha, T., Apichai, S., Saenjum, C., & Surh, Y. J. (2026). Heme Oxygenase-1 in Bone Remodeling: Molecular Mechanisms and Therapeutic Implications. Biomolecules. https://doi.org/10.3390/biom16091224
Vancouver
Pattananandecha T, Apichai S, Saenjum C, Surh YJ. Heme Oxygenase-1 in Bone Remodeling: Molecular Mechanisms and Therapeutic Implications. Biomolecules. 2026. doi:10.3390/biom16091224
BibTeX
@article{Pattananandecha2026,
author = {Pattananandecha, Thanawat and Apichai, Sutasinee and Saenjum, Chalermpong and Surh, Young-Joon},
title = {Heme Oxygenase-1 in Bone Remodeling: Molecular Mechanisms and Therapeutic Implications},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16091224}
}
EUVIMED